Prescription drug · NDA
Besivance (Besifloxacin) NDC 85766-257
Besifloxacin 6 mg/mL · Suspension · Ophthalmic · Sportpharm LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85766-257-05 | 8576602570585766025705 | 1 BOTTLE, DROPPER in 1 CARTON (85766-257-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Jul 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Besivance
- Generic name (nonproprietary)
- besifloxacin
- Active ingredients
- Besifloxacin — 6 mg/mL
- Dosage form
- Suspension
- Route
- Ophthalmic
- Labeler
- Sportpharm LLCNDC labeler code 85766
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022308
- Marketing start
- Listing expires
- Other FDA classes
- Quinolones (Chemical structure)
- Identifiers
- Product ID 85766-257_57410dc3-5ac5-b323-e063-6394a90a1a0aSPL ID 57410dc3-5ac5-b323-e063-6394a90a1a0aSPL set ID 80bf4981-4f86-4d25-83a5-7d5dfe0b22e0RxCUI 850305, 850309UNII BFE2NBZ7NX
- Pharmacologic class
- Quinolone Antimicrobial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485766025705followed by a unit qualifier and the quantityPackage 85766-0257-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BESIVANCE ® (besifloxacin ophthalmic suspension) 0.6% is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria: Aerococcus viridans* CDC coryneform group G Corynebacterium pseudodiphtheriticum* Corynebacterium striatum* Haemophilus influenzae Moraxella catarrhalis* Moraxella lacunata* Pseudomonas aeruginosa* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus hominis* Staphylococcus lugdunensis* Staphylococcus warneri* Streptococcus mitis group Streptococcus oralis Streptococcus pneumoniae Streptococcus salivarius* *Efficacy for this organism was studied in fewer than 10 infections. BESIVANCE ® (besifloxacin ophthalmic su…
Excerpt only. Read the full label for complete information.
About NDC 85766-257
- What is NDC 85766-257?
- 85766-257 is the product NDC for Besivance (besifloxacin), Besifloxacin 6 mg/mL suspension, listed with the FDA by Sportpharm LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Besivance (Besifloxacin).
- What is the active ingredient?
- Besifloxacin.
- Who is the labeler?
- Sportpharm LLC, NDC labeler code 85766. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Besivance?
- 3 other product NDCs are listed under this name. See all Besivance NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Besivance products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Bausch & Lomb Americas Inc. | 82260-466 | 82260-0466-05 |
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Sportpharm LLC | 85766-260 | 85766-0260-05 |
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Bausch & Lomb Incorporated | 24208-446 | 24208-0446-0224208-0446-05 |
Other NDCs under NDA 022308
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Bausch & Lomb Incorporated | 24208-446 |
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Bausch & Lomb Americas Inc. | 82260-466 |
| Besivancebesifloxacin | Besifloxacin 6 mg/mL | SuspensionOphthalmic | Sportpharm LLC | 85766-260 |